Dry eye disease is a common ocular condition that can significantly impair quality of life, and dysfunction of the meibomian glands is a major contributing factor. Advances in infrared meibography ...

26 Therapeutics is a preclinical-stage biotechnology company developing small-molecule therapies for dry eye disease and other meibomian gland disorders. The company's lead program is a topical, ...

Please provide your email address to receive an email when new articles are posted on . Subjective grading was significantly different between Visante OCT and Keratograph 5M for the lower eyelid but ...

Please provide your email address to receive an email when new articles are posted on . Tear lipid film was thicker with longer, wider meibomian glands with greater density and tortuosity but less ...

Dry eye disease is a condition that afflicts millions of people worldwide, causing constant discomfort and affecting their quality of life. One of the key culprits behind this condition is meibomian ...

TEL AVIV, Israel--(BUSINESS WIRE)--Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a new therapeutic class of Ophthalmic Keratolytics for ocular surface diseases, today ...

The study presents a large open-access collection of high-quality infrared images of upper eyelid meibomian glands, analyzed using AI. By combining multi-stage expert quality control with ...